Raymond James Financial’s abrdn Healthcare Investors HQH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27M Buy
1,229,661
+35,036
+3% +$690K 0.01% 1347
2026
Q1
$21.3M Buy
1,194,625
+11,694
+1% +$221K 0.01% 1427
2025
Q4
$22.4M Sell
1,182,931
-2,999
-0.3% -$56.6K 0.01% 1362
2025
Q3
$21.9M Sell
1,185,930
-113,714
-9% -$1.86M 0.01% 1355
2025
Q2
$20.1M Buy
1,299,644
+110,011
+9% +$1.7M 0.01% 1366
2025
Q1
$19.3M Buy
1,189,633
+251,977
+27% +$4.33M 0.01% 1337
2024
Q4
$15M Buy
+937,656
New +$16.6M 0.01% 1513

Other funds holding HQH

Raymond James Financial's HQH Position: Q2 2026 in Review

Raymond James Financial increased its abrdn Healthcare Investors (HQH) stake by 2.9% in Q2 2026, buying an estimated $690K and bringing the position to 1,229,661 shares worth $27M. The position accounts for 0.01% of the portfolio, ranked #1347.

Raymond James Financial first reported a position in HQH in Q4 2024 and has held it in 7 quarters since. 125 funds tracked by Wall St. Rank hold HQH as of Q2 2026.

  • Raymond James Financial held 1,229,661 shares of abrdn Healthcare Investors worth $27M as of Q2 2026.
  • Raymond James Financial bought 35,036 abrdn Healthcare Investors shares in Q2 2026, an estimated $690K.
  • abrdn Healthcare Investors made up 0.01% of Raymond James Financial's portfolio in Q2 2026, its #1347 holding.
  • Raymond James Financial first reported a position in abrdn Healthcare Investors in Q4 2024 and has held it in 7 quarters since.
  • 125 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.